Weight loss varies, but clinical research on semaglutide has shown average results around 1015% of body weight over time when paired with nutrition, activity, and ongoing medical care
Practical access strategies For patients in markets where both peptides are available, tirzepatide is the practical choice due to established availability, known dosing protocols, extensive clinical experience, and insurance coverage pathways
Retatrutide builds upon this concept by targeting GLP-1, GIP, and glucagon receptors simultaneously
Theres also some initial data showing increased availability of free testosterone thanks to these drugs, as well as improved sperm quality, though data is mixed
[(accessed on 15 November 2025)];2017 Available online: 69.Novo Nordisk Inc Wegovy (Semaglutide) Injection for Subcutaneous Use, U.S
The 1 mg arm of Phase 2 produced direct measurement